MARICONSEMarico Limited· Personal CareMinimalNeutral
Announced Wed, 6 May · 16:45 IST

Pursuant to Regulation 47 of the SEBI Listing Regulations, please find enclosed the newspaper extract of the audited consolidated financial results of the Company for the quarter and financial year ended March 31, 2026, approved by the Board of Directors at its meeting held on May 5, 2026 and published in Financial Express, Free Press Journal (English Daily) and Navshakti (Marathi Daily) today i.e. on May 6, 2026. The same is being made available on the website of the Company.

MARICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹818.00
prior close
₹818.85
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.3-0.3-0.6+1.5+2.8+1.9+2.1+2.4+1.8+0.6-1.6+4.0
Up moveDown movePending
AI summary

Marico Limited has published its audited consolidated financial results for Q4 and full year ended March 31, 2026. For Q4 FY26, revenue from operations was Rs 3,333 crore with net profit of Rs 391 crore and EPS of Rs 3.04 (basic). Comparing Q4 FY26 to Q4 FY25, revenue declined from Rs 3,537 crore, though net profit improved from Rs 447 crore. For the full year FY26, revenue grew to Rs 13,611 crore versus Rs 10,831 crore in FY25, representing approximately 26% year-on-year revenue growth. Net profit for FY26 stood at Rs 1,762 crore with EPS of Rs 13.62 (basic), up from Rs 12.59 in FY25. The Board recommended a dividend of Rs 4 per equity share, subject to shareholder approval at the 38th Annual General Meeting.

Likely market impact

The results show strong full-year revenue growth of about 26% driven by robust operational performance. The sequential Q4 revenue dip may raise questions about seasonal trends, but the annual performance appears solid with improved profitability metrics. The dividend recommendation signals confidence in the company's financial health.